Intended for healthcare professionals

Editorials

SGLT2 inhibitors and kidney outcomes in the real world

BMJ 2020; 369 doi: https://doi.org/10.1136/bmj.m1584 (Published 29 April 2020) Cite this as: BMJ 2020;369:m1584

Linked Research

Use of sodium-glucose co-transporter 2 inhibitors and risk of serious renal events

Linked Analysis

Communicating emerging risks of SGLT2 inhibitors

Article usage

Article metrics provide readers and authors with an indication of how often a specific article has been accessed month by month. It counts three formats - abstract/extract, full text and pdf. The page is updated each day.

Usage statistics: May 2020 to January 2023

Rendering graph...
AbstractFullPdf
May 202016031832523
Jun 20205396331
Jul 20202683218
Aug 2020251319
Sep 20201904518
Oct 20202123914
Nov 20201812510
Dec 20201473311
Jan 2021123207
Feb 2021120148
Mar 20211482718
Apr 2021225289
May 20211201312
Jun 202173108
Jul 20216243
Aug 20217683
Sep 20217761
Oct 20217122
Nov 202112989
Dec 20218562
Jan 202281193
Feb 20229365
Mar 20227073
Apr 20229881
May 2022105105
Jun 202252112
Jul 20223551
Aug 20223095
Sep 202233131
Oct 20223891
Nov 20223483
Dec 20225140
Jan 202337122
Total54572367748